Redmile Biopharma Investments Iii, L.P.
Private Equity Fund · Delaware
Advised by Redmile Group, Llc · reported Jul 2024
Gross asset value
$1.2B
Beneficial owners
330
Minimum investment
$5.0M
Adviser & related persons own
5%
Structure & investors
- SEC fund ID
- 805-5445849187
- Exclusion
- 3(c)(7)
- Fund of funds
- No
- Owned by funds of funds
- 18%
- Non-US ownership
- 28%
- Adviser's clients invested
- 4%
Reported by the adviser in Form ADV Section 7.B.(1), filing of July 2024. Figures are as reported by the adviser and not independently verified.